Rating History for Anchiano Therapeutics (ANCN) by Ladenburg Thalmann

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2019 Matthew Kaplan Downgrade Neutral
(Buy)
N/A
(N/A)
1.92
(4.71)
145.31% Details